Comparing with abdominal obesity, general obesity had a greater contribution to the effect of ALT (35.7% vs 30.3%), AST (2.4% vs 1.2%), GGT (38.0% vs 30.6%), and AST/ALT (73.9% vs 66.9%) levels, as well as the prevalence of abnormal ALT (147.3% vs 141.0%), abnormal AST (20.8% vs 9.1%), and abnormal GGT (44.1% vs 33.9%). This evidence concerns the gene GPT and Abdominal obesity.